P
Paclitaxel
Availability of ACE Drug Guidance
No
Biologics Drug Information Overview
No
Post-marketing information
Dear Healthcare Professional Letters
Subsidy Information and Financing Scheme
Cancer Drug and Clinical Indication listed in the MediShield Life Outpatient Cancer Drug List
Standard Drug List
Active ingredient: Paclitaxel
General information
Subsidy Information and Financing Scheme
[SDL] Paclitaxel Concentrate For Infusion 150 mg/25 mL, 300 mg/50 mL
[MSHL] Paclitaxel Vial 150 mg/25 mL, 300 mg/50 mL
For cancer treatment.
Drug Guidance for Subsidy
Not Applicable
Post Marketing Information
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Availability information
Formulation | Public Healthcare Institution |
|---|---|
Concentrate For Infusion 150 mg/25 mL |
|
Concentrate For Infusion 300 mg/50 mL |
|
Registered Product(s) Information
Clinical and product info
Clinical info | Product Info |
|---|---|
Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch. The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice. | Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch for the most updated product information. |
Intravenous
ACLIPAK CONCENTRATE FOR SOLUTION FOR INFUSION 6MG/ ML [SIN13752P]
CYTAX PACLITAXEL INJECTION USP CONCENTRATE 6 MG/ ML [SIN15632P]*
FONKOPAC CONCENTRATE FOR SOLUTION FOR INFUSION 6MG/ML [SIN16410P]*
PACLITAXEL ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 6MG/ML [SIN16392P]*
PACLITERO 100 SOLUTION FOR INJECTION 100MG/16.7ML [SIN16436P]
* Clinical information is available for this product.